Mark "Tony" Mixon

EM PharmD navigating the transition after a PGY-2 in ID |Ski/Backpack/MTB/Terrible Climber/Trail Run| BCPS | BCIDP | BCCCP

[Mark "Tony" Mixon @IDintheED]

Our paper in @AJHPOfficial demonstrating the UTI pocket card we developed significantly increased preferred antibiotic prescribing, dose, and frequency in the ED is available: https://t.co/K813pqIOED

@PCC_PharmD @RyanRogoPharmD @garyDpeksa

[RhAPP @RheumAPP]

Registration is now open! 🗓️
Join us virtually from the East or West Coast for the upcoming Navigating Anti-TNF Cycling and MOA Switching in Rheumatoid Arthritis meeting series.
Save your spot today! https://t.co/wmhjzYHXf3

[RhAPP @RheumAPP]

RhAPP 2025 is coming in hot with all-new bootcamp sessions!
Don’t miss your chance to dive into ILD and Obesity + IMIDs with expert-led, case-based learning tailored for APPs.

💥 Level up your clinical skills—register today on https://t.co/yrGGToUNLA!

[RhAPP @RheumAPP]

How quickly does Ixekizumab start working? Claudia Rivera Salas, DNP, breaks down the timing of clinical efficacy and what patients can expect when starting treatment for psoriasis and psoriatic arthritis!💥

🎥 Watch now! https://t.co/qM4vKqUuBl #Psoriasis #PsoriaticArthritis

[RhAPP @RheumAPP]

Introducing… A Step Into Rheum!

Your all-in-one resource hub for aspiring #Rheumatology APPs! This comprehensive program is designed to inspire & equip you with the tools to excel in your career.

➡️ Learn more and start your journey: https://t.co/ZCPp7a6hFr

[Charlie Foster  @cjfstr]

Nice review of induction agents in the recent issue of CCM (free) https://t.co/XFqCA4H4bK

[Mark "Tony" Mixon @IDintheED]

Good few tweets on how to use PCT appropriately given available evidence

[Brad Spellberg @BradSpellberg]

I know this is confusing, but PCT hasnt been studied in RCTs as a DIAGNOSTIC test. It was studied as a PROGNOSTIC BIOMARKER. Several implications.

1) We don't use PCT to diagnose anything. It's not to Dx bacterial vs. viral PNA. Sensitivity/specificity are not really relevant.

[RhAPP @RheumAPP]

In this new FAQ video, Kyle George dives into the clinical, genetic, and radiographic differences between Axial PsA and AS, helping to clarify their unique characteristics for better diagnosis and management! Check it out at: https://t.co/omMWklBuC1

[Mark "Tony" Mixon @IDintheED]

@EMVinsanity some how, some way I told you or someone you work with so

[Mark "Tony" Mixon @IDintheED]

I’m going on an “I told you so” tour

@PCC_PharmD I told you so like 8 times
@PharmD_intheED I told you so after some bourbon
@LRayRx pretty sure I told you so
#tiwtterx I.told. you. so.

More I told you so’s to come as I remember ‘em

[Amy Magdalany, PharmD, BCEMP @AmyMagdalany]

Oral cephs vs FQ & TMP-SMX for the tx of pyelo in patients dc from the ED 💊
No diff in tx failure between cephs vs FQ and TMP-SMX groups (17.2% of cephs vs 22.5% of FQ & TMP-SMX) 💯
42% Cephalexin & 35.5% Cefdinir 😳

Do you avoid Cefdinir due to the low oral bioavailability?

[Mark "Tony" Mixon @IDintheED]

@DMianzo I told you so

[RhAPP @RheumAPP]

In this RhAPPcast episode, Amanda Mixon, PA-C , teams up with Jeannette Hart, PA-C, to unpack the consequences of delaying treatment for rheumatoid arthritis and spondyloarthropathies. Tune in at https://t.co/9WibDd8VS3

[RhAPP @RheumAPP]

The Step up to Rheum initiative is an amazing resource for APPs! Developed and taught by expert Rheumatology APPs, there are 198 lessons and 700 assessment questions available for your education! Check it out here: https://t.co/4omKMOTZ43

[Mark "Tony" Mixon @IDintheED]

@PCC_PharmD @pharmsohardnet We can only guess what would happen if they had more than 24 patients right? Which isn't exactly science.

This study shows cefdinir and cephalexin work the same in UTI.

Anyone using this to bash cefdinir is just parroting what they've read on this app #twitterx #dogma

[Mark "Tony" Mixon @IDintheED]

@Novemhc @RheumAPP

[RhAPP @RheumAPP]

The RhAPP National Conference boasts the unmatched opportunity to learn directly from KOL's in Rheumatology. Whether you're new to Rheumatology, or a seasoned APP you are guaranteed to take home new knowledge that will elevate your practice!

[Mark "Tony" Mixon @IDintheED]

@PCC_PharmD @PharmD_intheED And if there’s any downside. Which the SSTI data suggests is yes in the form of increased diarrhea… for most patients you aren’t gaining anything but you are increasing AEs

[Mark "Tony" Mixon @IDintheED]

@PCC_PharmD @KaitEMPharmD @medic2pharmd Didn’t know I could start at 100 🤔

[Stephanie Wong @PharmD_Wong]

Oliver taking a break while we take a break 🥹

#EMPRx24